Entry Point Capital, LLC Corcept Therapeutics Inc Transaction History
Entry Point Capital, LLC
- $68.4 Billion
- Q2 2024
Shares
2 transactions
Others Institutions Holding CORT
# of Institutions
319Shares Held
88.1MCall Options Held
1.07MPut Options Held
822K-
Black Rock Inc. New York, NY16.5MShares$898 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.55MShares$519 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.24MShares$447 Million11.51% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.91MShares$375 Million0.4% of portfolio
-
Parallel Advisors, LLC3.82MShares$207 Million3.2% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $5.82B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...